Hard To Treat Stock Debt To Equity
Hard to Treat fundamentals help investors to digest information that contributes to Hard To's financial success or failures. It also enables traders to predict the movement of Hard Stock. The fundamental analysis module provides a way to measure Hard To's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hard To stock.
Hard |
Hard to Treat Company Debt To Equity Analysis
Hard To's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Hard To Debt To Equity | 0.21 % |
Most of Hard To's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hard to Treat is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, Hard to Treat has a Debt To Equity of 0.206%. This is 99.62% lower than that of the Biotechnology sector and 98.94% lower than that of the Health Care industry. The debt to equity for all United States stocks is 99.58% higher than that of the company.
Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
| All Next | Launch Module |
Hard Fundamentals
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 254.37 K | ||||
| Shares Outstanding | 5.48 B | ||||
| Price To Sales | 0.01 X | ||||
| Revenue | 5.39 M | ||||
| Gross Profit | 1.42 M | ||||
| EBITDA | 1.03 M | ||||
| Net Income | 621.6 K | ||||
| Cash And Equivalents | 202.9 K | ||||
| Total Debt | 1.54 M | ||||
| Debt To Equity | 0.21 % | ||||
| Current Ratio | 2.27 X | ||||
| Cash Flow From Operations | 655.71 K | ||||
| Beta | 0.27 | ||||
| Market Capitalization | 54.82 K | ||||
| Total Asset | 4.56 M | ||||
| Retained Earnings | 1.4 M | ||||
| Working Capital | (508 K) | ||||
| Current Asset | 596 K | ||||
| Current Liabilities | 1.1 M | ||||
| Net Asset | 4.56 M |
About Hard To Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hard to Treat's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hard To using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hard to Treat based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Hard Stock Analysis
When running Hard To's price analysis, check to measure Hard To's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hard To is operating at the current time. Most of Hard To's value examination focuses on studying past and present price action to predict the probability of Hard To's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hard To's price. Additionally, you may evaluate how the addition of Hard To to your portfolios can decrease your overall portfolio volatility.